Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
Sebastian Stintzing
Journal of Cancer Research and Clinical Oncology, 2014
View PDFchevron_right
Primary tumor location as a prognostic factor in metastatic colorectal cancer
Heinz-josef Lenz
Journal of the National Cancer Institute, 2015
View PDFchevron_right
Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy
Emanuela Scarpi
International journal of molecular sciences, 2017
View PDFchevron_right
Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab
Masahiro Hirakawa
Scientific Reports, 2020
View PDFchevron_right
Treatment choices in metastatic colorectal cancer according to sidedness and RAS/BRAF status: a national survey by the Brazilian Gastrointestinal Tumors Group (GTG)
Gabriel Prolla
Brazilian Journal of Oncology
View PDFchevron_right
Clinical and Pathological Differences of Left and Right Colorectal Cancer and Prognostic Survival Analysis
united prime
Clinics of Surgery , 2021
View PDFchevron_right
Right- and left-sided colorectal cancers respond differently to cetuximab
YI YU
Chinese journal of cancer, 2015
View PDFchevron_right
Comparison of Treatment Outcomes between Right- and Left-sided Colorectal Adenocarcinoma after Adjuvant Chemotherapy
Mel Valerie Cruz
Asian Pacific Journal of Cancer Care, 2021
View PDFchevron_right
Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO
Alberto Zaniboni
Annals of Oncology, 2018
View PDFchevron_right
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer
Axel Grothey
British Journal of Cancer
View PDFchevron_right
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials
Ken Shimada
Clinical colorectal cancer, 2016
View PDFchevron_right
Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)
Devavrat Arya
Frontiers in Oncology, 2020
View PDFchevron_right
Assessment of survival and prognostic factors in metastatic colorectal cancer patients treated with first-line bevacizumab-based therapy
Nalan Akgul Babacan
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2019
View PDFchevron_right
Prognostic impact of primary tumor location on survival time in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus oxaliplatin-based chemotherapy: A subgroup analysis of the JACCRO CC-05/06
Ken Shimada
Journal of Clinical Oncology, 2016
View PDFchevron_right
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
Nigel Spry
The Lancet, 2000
View PDFchevron_right
Metastatic Colorectal Cancer: Evolution of the Response Rate and Survival with Therapeutic Progress
Amira Daldoul
Open Journal of Gastroenterology, 2016
View PDFchevron_right
Prognostic Factors and Differences in Survival of Right and Left Colon Carcinoma: A STROBE Compliant Retrospective Cohort Study
FRANCISCO OCHOA-CARRILLO
Archives of Medical Research, 2019
View PDFchevron_right
The side of the primary tumor affects overall survival in colon adenocarcinoma: an analysis of the national cancer database
Christopher Mantyh
Techniques in Coloproctology, 2019
View PDFchevron_right
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Miriana Moran
Molecular Cancer Therapeutics
View PDFchevron_right
Stage-based Variation in the Effect of Primary Tumor Side on All Stages of Colorectal Cancer Recurrence and Survival
Belinda Lee
Clinical colorectal cancer, 2018
View PDFchevron_right
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database
Matthew Seymour
European journal of cancer (Oxford, England : 1990), 2018
View PDFchevron_right
Impact of tumor sidedness on survival and recurrence patterns in colon cancer patients
Hyuk Hur
Annals of Surgical Treatment and Research
View PDFchevron_right
Correlation of Tumor Location to Clinical Outcomes in Colorectal Cancer: A Single-institution Retrospective Analysis
Raffaele Macarone Palmieri
Anticancer Research, 2019
View PDFchevron_right
The Importance of the Tumor Sidedness and Its Relationship with Other Clinicopathological Features in Patients with Colorectal Cancer
Halis Yerlikaya
Kafkas Journal of Medical Sciences, 2021
View PDFchevron_right
Factors Affecting Prognosis in Metastatic Colorectal Cancer Patients
Ersin Ozaslan
Asian Pacific Journal of Cancer Prevention, 2015
View PDFchevron_right
Colorectal Cancer Survival: An Analysis of Patients With Metastatic Disease Synchronous and Metachronous With the Primary Tumor
Timothy Price, Christos Karapetis
2013
View PDFchevron_right
Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location
Dan Aderka
Cancer, 2013
View PDFchevron_right
Clinicoepidemiological Study and Survival Analysis of Right versus Left Sided Colon Cancer Patients
amr faraj
The Egyptian Journal of Hospital Medicine
View PDFchevron_right
Impact of Tumor Location and Variables Associated With Overall Survival in Patients With Colorectal Cancer: A Mayo Clinic Colon and Rectal Cancer Registry Study
Cassia Wang
Frontiers in Oncology, 2019
View PDFchevron_right
The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis
Philip Ituarte
Journal of Surgical Research, 2020
View PDFchevron_right
Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran
Mohammad Aziz Rasouli
Medicine®, 2017
View PDFchevron_right
Predictors of Survival in Stage IV Metastatic Colorectal Cancer
Efstathios Antoniou
Anticancer Research, 2010
View PDFchevron_right